PFE · News · 20260922N

COVID Product Demand Decline

PFIZER INC · 2026-09-22 · Importance 44 · Surprise 24

Pfizer is shifting away from COVID-19 products as COVID-related revenue is expected to decline significantly. The portfolio transition reflects lower demand for Comirnaty and other pandemic products after the peak vaccination cycle. New medicines, vaccines, and oncology products are being positioned to offset the COVID-related weakness.

Key facts